Why should we use CAR30 memory T cells to treat Hodgkin and T-cell lymphoma?

‘Off-the-shelf’ EBV-specific CAR-T cells for Hodgkin lymphomaПодробнее

How long do CAR-T Cells work? #myelomaПодробнее

Dual-targeting CD30/PDL1 CAR-T therapy in Hodgkin lymphomaПодробнее

Winship Webinar: Updates in CAR T-Cell Therapy for Non-Hodgkin LymphomaПодробнее

Understanding CAR T Cell Therapy and Lymphoma | LRF WebinarsПодробнее

Infusion of CD30 CAR T-cells following AuHCT in patients with lymphomaПодробнее

CAR T-cell in lymphomaПодробнее

CD30-directed CAR-Ts co-expressing CCR4 in R/R HL and CD30+ CTCLПодробнее

Understanding Peripheral T-Cell Lymphoma with Dr. Pamela Blair AllenПодробнее

An Overview of Peripheral T-Cell LymphomaПодробнее

T-cell LymphomaПодробнее

Aggressive Lymphoma subtypes and treatment optionsПодробнее

CAR T-cells in lymphoma: new advances and practical aspectsПодробнее

CAR T-Cell Therapy Saved My Life: Robyn's Non-Hodgkin Lymphoma Story | The Patient StoryПодробнее

Update on Immunotherapy in the Treatment of Lymphoma | LRF WebinarsПодробнее

Understanding Immunotherapy for the Treatment of Lymphoma with Elise Chong, MDПодробнее

Treating T-Cell LymphomaПодробнее

Safety and efficacy of rapcabtagene autoleucel (YTB323), a CAR T-cell therapy, in r/r DLBCLПодробнее

Immunotherapy Treatments for B-Cell Non-Hodgkin's Lymphoma: CAR-T Cells - Blood Cancer Video LibraryПодробнее